MARINACCIO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 4.254
EU - Europa 1.985
AS - Asia 1.890
SA - Sud America 451
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 65
OC - Oceania 5
Totale 8.768
Nazione #
US - Stati Uniti d'America 4.171
SG - Singapore 801
IT - Italia 636
CN - Cina 442
BR - Brasile 353
DE - Germania 293
HK - Hong Kong 219
SE - Svezia 207
RU - Federazione Russa 195
FR - Francia 158
UA - Ucraina 142
VN - Vietnam 121
FI - Finlandia 115
GB - Regno Unito 113
IN - India 61
BD - Bangladesh 58
CA - Canada 38
AR - Argentina 28
ID - Indonesia 22
MX - Messico 22
PK - Pakistan 21
BE - Belgio 20
IQ - Iraq 19
JP - Giappone 17
CO - Colombia 16
NL - Olanda 16
TR - Turchia 16
ZA - Sudafrica 15
PH - Filippine 14
PL - Polonia 14
VE - Venezuela 14
EC - Ecuador 13
AT - Austria 12
IE - Irlanda 12
ES - Italia 11
LT - Lituania 10
MA - Marocco 10
SA - Arabia Saudita 10
CL - Cile 8
UZ - Uzbekistan 8
KR - Corea 7
PY - Paraguay 7
TN - Tunisia 7
JM - Giamaica 6
KE - Kenya 6
MY - Malesia 6
AU - Australia 5
AZ - Azerbaigian 5
CR - Costa Rica 5
IR - Iran 5
PE - Perù 5
RO - Romania 5
TH - Thailandia 5
AL - Albania 4
CI - Costa d'Avorio 4
EG - Egitto 4
JO - Giordania 4
UY - Uruguay 4
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
GA - Gabon 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
LY - Libia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
AG - Antigua e Barbuda 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
Totale 8.641
Città #
Singapore 435
Ashburn 380
Fairfield 329
Chandler 323
Woodbridge 307
San Jose 281
Jacksonville 264
Hong Kong 215
Milan 198
Houston 190
Nyköping 175
Ann Arbor 168
Wilmington 131
Beijing 130
Seattle 125
Cambridge 118
Council Bluffs 118
Nanjing 80
New York 71
Lawrence 70
Roxbury 70
Rome 69
Lauterbourg 66
Los Angeles 63
Boardman 52
Dallas 51
Des Moines 44
Bari 41
Ho Chi Minh City 39
Helsinki 38
Santa Clara 37
São Paulo 35
Inglewood 31
Columbus 30
Princeton 29
Buffalo 26
Dearborn 26
Hanoi 25
Munich 25
Brussels 20
Moscow 20
Frankfurt am Main 19
San Diego 19
Hebei 18
Orem 18
Figino 17
Chicago 16
Shenyang 16
Jiaxing 15
London 15
San Francisco 15
Tokyo 15
Brooklyn 14
Changsha 13
Chennai 13
Falkenstein 13
Montreal 13
Warsaw 13
Dublin 12
Poplar 12
Turku 12
Phoenix 11
Nanchang 10
Jakarta 9
Johannesburg 9
Naples 9
Atlanta 8
Boston 8
Denver 8
Guangzhou 8
Mumbai 8
Paris 8
Rio de Janeiro 8
Toronto 8
Turin 8
Washington 8
Baghdad 7
Catania 7
Hefei 7
Nuremberg 7
Pescara 7
Tianjin 7
Bologna 6
Da Nang 6
Lahore 6
Mexico City 6
Tashkent 6
Vienna 6
Amsterdam 5
Ankara 5
Asunción 5
Bangkok 5
Biên Hòa 5
Caracas 5
Charlotte 5
Manaus 5
Medellín 5
Nairobi 5
Porto Alegre 5
Salvador 5
Totale 5.509
Nome #
Valutazione dell'efficienza dello Sniff-test (test delle amine) nella diagnosi di infezione da Gardnerella Vaginalis 207
Higher prevalence of chronic endometritis in women with endometriosis: a possible etiopathogenetic link 205
Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. 204
Possible Inflammatory Origin of Endometrial Polyps 196
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 183
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 175
A dominant ovarian follicle induces unilateral changes in the origin of the blood supply to the tubal corner of the uterus 171
NEOADJUVANT CHEMOTHERAPY (NACHT) FOR LOCALLY ADVANCED CERVICAL CANCER (LACC): OUR EXPERIENCE WITH TIP (TAXOL+IFOSFAMIDE+PLATINUM) REGIMEN 171
Detection of chronic endometritis at fluid hysteroscopy 156
Gastrointestinal stromal tumors mimicking gynecological masses on ultrasound: a report of two cases 154
"L'associazione Mitoxantrone intraperitoneale e Timopentina come terapia dell'ascite ricorrente nel carcinoma ovarico". 152
Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. 149
Pregnancy related cancer in Apulia. A population based linkage study. 147
Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: Replication 144
Microbiological findings in endometrial specimen: our experience 143
Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: A Pilot Study 142
Chronic Endometritis Due to Common Bacteria Is Prevalent in Women With Recurrent Miscarriage as Confirmed by Improved Pregnancy Outcome After Antibiotic Treatment 142
Hysteroscopic diagnosis and treatment of endocervical ossification: a case report 137
Serum half life of CA 72.4 during adjuvant chemotherapy for ovarian cancer 134
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary 131
Enhanced osteoclastogenesis in women after natural delivery 131
Intraperitoneal mitoxantrone in the treatment of recurrent ascites from progressive epithelial ovarian cancer 127
Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9). 127
Gemcitabina in monochemioterapia nella terapia di salvataggio del carcinoma ovarico platino-taxol resistente 127
Failure of CA72.4 in early detection of recurrent ovarian cancer 126
"I nuovi parametri ematologici valutati nella gravidanza a termine. Nota II: Ampiezza della distribuzione piastrinica (PDW)”. 124
An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature 121
Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group 121
Phase II study of weekly topotecan in recurrent ovarian cancer: duration of response based on a prolonged follow-up 119
Reliability of diagnostic fluid hysteroscopy in the assessment of cervical invasion by endometrial carcinoma:a a comparative study with transvaginal sonography and MRI 115
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel:the Multicenter Italian Trial in Ovarian Cancer (MITO-4) retrospective study 114
Predictive factors for pain experienced at office fluid minihysteroscopy 110
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study 110
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study 108
Pretreatment serum hemoglobin as a prognostic factor in epithelial ovarian cancer 107
Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study 106
Neoplasie ginecologiche in pazienti con epatopatia cronica. III Carcinoma della Cervice 106
Mioma uterino gigante: descrizione di un caso e revisione della letteratura 103
Ebstein's anomaly 103
High prevalence of chronic endometritis in women with nonstructural abnormal uterine bleeding and benefits of antimicrobial treatment on blood loss pattern: A prospective, observational study 102
Whose surgery is this? Endometriosis of the round ligament 101
Infezione da Gardnerella Vaginalis e contraccezione 101
Uterine cavity findings at fluid mini-hysteroscopy in patients with no evidence of uterine cavity abnormality at TVE who repeatedly failed to conceive at IVF. 101
IS THERE STILL AN AVOIDABLE FRACTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS WITH HEPARIN-PROPHYLAXIS - THE RESULTS OF A CASE-CONTROL SURVEILLANCE 101
Histerostopic diagnosis and treatment of endocervical ossification: a case report 97
Risk groups and adjuvant therapy in surgical stated endometrial cancer patients.A randomized multicentre study comparing chemotherapy with radiation therapy 96
Cervical Intraepithelial Neoplasia: a psycho-immunological outlook 93
Approccio psicologico al cancro. Risultati preliminari di una ricerca su cancro e fattori di personalità 93
PRIMARY FALLOPIAN TUBE CARCINOMA : ANALYSIS OF 25 PATIENTS 93
Il controllo dell'ascite ricorrente secondaria a carcinoma ovarico in ricaduta con mitoxantrone intraperitoneale 91
“Failure of CA 72.4 to detect asymptomatic recurrent ovarian carcinoma.” 91
Paclitaxel, ifosfamide, and cisplatin regimen as neoadjuvant chemotherapy in young women with locally advanced squamous cervical cancer 89
I nuovi parametri ematologici valutati nella gravidanza a termine. Nota I: Ampiezza della distribuzione eritrocitaria (RDW) 86
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation? 85
Oral etoposide as a salvage therapy in recurrent epithelial ovarian cancer 85
Chronic Endometritis in Infertile Women: Impact of Untreated Disease, Plasma Cell Count and Antibiotic Therapy on IVF Outcome-A Systematic Review and Meta-Analysis 83
Pretreatment normalization of mild anemia with epoietin alfa predicts long-term outcome for women with epithelial ovarian cancer 82
Trabectidin as single-agent in heavily pretreated patients with relapsed ovarian cancer (ROC): results from a retrospective study 82
Vulvar Malignant Melanoma: A Narrative Review 82
Utilizzo di criteri sonoembriologici nella valutazione dell'età gestazionale 78
Mesotelioma multicistico del peritoneo. Scattone A, Pennella A, Marinaccio M, Lonigro G, Ricco R, Pollice L, Serio G 78
Surgical and Medical Treatment of Clear Cell Ovarian Cancer: Results From the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 Retrospective Study 78
Rapporti tra alexitimia, espressioni linfocitarie e displasie (CIN) della cervice uterina 78
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 75
The value of CA125 in the diagnosis of adenomyosis 74
Pclitaxel, ifosfamide, and Cisplatin regimen as neoadjuvat chemotherapy in young women with locally advanced squamous cervical cancer 74
Serum beta 2-microglobulin as a prognostic indicator in epithelial ovarian cancer 74
TIP (Taxol, Ifosfamide, Cisplatin) regimen as neoadjuvant chemotherapy in young women with locally advanced squamous cervical cancer 73
Surgical and medical treatment of clear cell ovarian cancer: results from the Multicenter Ovarian Trial (Mito )9 restrospective study 72
Leuprolide acetate as a salvage-therapy in relapsed epithelial ovarian cancer. 72
Il trattamento delle infezioni ginecologiche: confronto tra Carumonam + Piperacillina versus Aztreonam + Piperacillina. 71
Topotecan compared with no therapy afetr response to surgery and Carboplatin/Paclitaxel in patients with ovarian cancer.MITO-1 randomized study 70
Weekly topotecan as a salvage-therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer 70
Rapporti tra cervicodisplasie, linfocitogramma periferico e alessitamia. Studio in fase II. 66
Sonoembryological criteria in the evaluation of gestational age 65
Pregnancy and fetal outcome in women with personal anamnesis of neoplasia treated with chemotherapy: A study on 29 cases 62
Serum progesterone, estradiol-17 beta and testosterone at the time of relapse in patients with epithelial ovarian cancer 59
A Normally Carried to Term Pregnancy with a Intrauterine Device (IUD) in Place: Not a Mission Impossible 57
Herlyn-Werner-Wunderlich associated hematometra mimicking endometrioid neoformation: A rare case report 55
Pretreatment normalization of mild anemia with epoietin alfa: impact on the outcome in epithelial ovarian cancer 53
Case Report: Advanced colorectal cancer diagnosed and treated with chemotherapy during pregnancy 32
Totale 8.768
Categoria #
all - tutte 35.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022390 0 0 11 47 16 13 15 46 19 19 100 104
2022/2023834 107 79 66 84 116 121 8 76 145 4 11 17
2023/2024267 32 58 14 14 21 62 3 6 12 12 6 27
2024/20251.252 31 17 109 46 24 93 107 108 43 78 171 425
2025/20262.888 409 141 149 342 343 134 285 110 300 238 74 363
2026/2027388 93 151 144 0 0 0 0 0 0 0 0 0
Totale 8.768